Persistent suicide risk in clinically improved schizophrenia patients: Challenge of the suicidal dimension

Neuropsychiatric Disease and Treatment

Volumn 6, Issue 1, 2010, Pages 633-638

  Shrivastava, Amresh ^a   Johnston, Megan E ^b   Shah, Nilesh ^c   Innamorati, Marco ^d   Stitt, Larry ^e   Thakar, Meghana ^c   Lester, David ^f   Pompili, Maurizio ^d,g  

^a Silver Mind Hospital and Mental Health Foundation of India   (India)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MUMBAI   (India)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f RICHARD STOCKTON COLLEGE OF NEW JERSEY   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Prevention; Schizophrenia; Suicide risk

Indexed keywords

EID: 79956149872     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S12044     Document Type: Article

References (43)

1. Pompili M, Lester D, Innamorati M, Tatarelli R, Girardi P. Assessment and treatment of suicide risk in schizophrenia. Expert Rev Neurother. 2008;8(1):51-74.
2. Roy A, Pompili M. Management of schizophrenia with suicide risk. Psychiatr Clin North Am. 2009;32(4):863-883.
3. Miles CP. Conditions predisposing to suicide: A review. J Nerv Ment Dis. 1977;164(4):231-246.
4. Caldwell CB, Gottesman II. Schizophrenia-a high-risk factor for suicide: Clues to risk reduction. Suicide Life Threat Behav. 1992;22(4):479-493.
5. Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: A reexamination. Arch Gen Psychiatry. 2005;62(3):247-253.
6. Inskip HM, Harris EC, Barraclough B. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry. 1998;172:35-37.
7. Ettlinger R. Evaluation of suicide prevention after attempted suicide. Acta Psychiatr Scand Suppl. 1975;260:1-135.
8. Meltzer HY. Suicidality in schizophrenia: A review of the evidence for risk factors and treatment options. Curr Psychiatry Rep. 2002;4(4):279-283.
9. Pompili M, Mancinelli I, Ruberto A, Kotzalidis GD, Girardi P, Tatarelli R. Where schizophrenic patients commit suicide: A review of suicide among inpatients and former inpatients. Int J Psychiatry Med. 2005;35(2):171-190.
10. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 1997;170:205-228.
11. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry. 1997;171:502-508.
12. Munk-Jorgensen P, Mortensen PB. Incidence and other aspects of the epidemiology of schizophrenia in Denmark, 1971-87. Br J Psychiatry. 1992;161:489-495.
13. Licht RW, Mortensen PB, Gouliaev G, Lund J. Mortality in Danish psychiatric long-stay patients, 1972-1982. Acta Psychiatr Scand. 1993;87(5):336-341.
14. Heila H, Isometsa ET, Henriksson MM, Heikkinen ME, Marttunen MJ, Lonnqvist JK. Suicide and schizophrenia: A nationwide psychological autopsy study on age-and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am J Psychiatry. 1997;154(9): 1235-1242.
15. Meltzer HY, Conley RR, de Leo D, et al. Intervention strategies for suicidality. J Clin Psychiatry Audiograph. 2003;6:1-16.
16. Nordentoft M, Laursen TM, Agerbo E, Qin P, Hoyer EH, Mortensen PB. Change in suicide rates for patients with schizophrenia in Denmark, 1981-97: Nested case-control study. BMJ. 2004;329(7460):261.
17. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry. 1999; 156(2):181-189.
18. Pompili M, Lester D, Grispini A, et al. Psychiatry Res. 2009;167(3): 251-257.
19. Shrivastava A, Gopa S. Comparative study of risperidone and haloperidol on clinical and psychosocial parameters in treatment of schizophrenia: A randomised open trial. Ind J Psychiatry. 2000;42(1):52-56.
20. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276.
21. Guy W. ECDEU Assessment Manual for Psychopharmacology. Washington, DC: US Department of Health, Education, and Welfare; 1976.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
23. Bertolote JM, Fleischmann A, de Leo D, Wasserman D. Psychiatric diagnoses and suicide: Revisiting the evidence. Crisis. 2004; 25(4):147-155.
24. de Leo D. Suicide prevention is far more than a psychiatric business. World Psychiatry. 2004;3(3):155-156.
25. Pouliot L, de Leo D. Critical issues in psychological autopsy studies. Suicide Life Threat Behav. 2006;36(5):491-510.
26. Shneidman ES. Final contribution to suicidology. In: Pompili M, editor. Suicide in the Words of Suicidologists. New York, NY: Nova Science Publishers Inc; In press.
27. Shneidman ES. How I read. Suicide Life Threat Behav. 2005; 35(2):117-120.
28. Lester D. Suicide as a Learned Behavior. Springfield, IL: Charles Thomas; 1987.
29. Lester D. Questions and Answers about Suicide. Philadelphia, PA: The Charles Press; 1989.
30. Leenaars A. Psychotherapy with Suicidal People. Chichester, UK: John Wiley; 2004.
31. Bertolote JM, Fleischmann A, de Leo D, Wasserman D. Suicide and mental disorders: Do we know enough? Br J Psychiatry. 2003;183: 382-383.
32. Pompili M, Ruberto A, Kotzalidis GD, Girardi P, Tatarelli R. Suicide and awareness of illness in schizophrenia: An overview. Bull Menninger Clin. 2004;68(4):297-318.
33. Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: The hopelessness scale. J Consult Clin Psychol. 1974;42(6):861-865.
34. Beck AT, Steer RA. Beck Hopelessness Scale-Manual. San Antonio, TX: Harcourt Brace Javanovich, Inc.; 1988.
35. Drake RE, Bartels SJ, Torrey WC. Suicide in schizophrenia: Clinical approaches. In: Williams R, Dalby JT, editors. Depression in Schizophrenia. New York, NY: Plenum Press; 1989:153-169.
36. Pompili M, Mancinelli I, Girardi P, Tatarelli R. Nursing schizophrenic patients who are at risk of suicide. J Psychiatr Ment Health Nurs. 2003;10(5):622-624.
37. Pompili M, Mancinelli I, Girardi P, Tatarelli R. Making sense of nurses' role in the prevention of suicide in schizophrenia. Issues Ment Health Nurs. 2004;25(1):5-7.
38. Morgan HG, Priest P. Assessment of suicide risk in psychiatric inpatients. Br J Psychiatry. 1984;145:467-469.
39. Morgan HG, Priest P. Suicide and other unexpected deaths among psychiatric in-patients. The Bristol confidential inquiry. Br J Psychiatry. 1991;158:368-374.
40. Schwartz DA, Flinn DE, Slawson PF. Suicide in the psychiatric hospital. Am J Psychiatry. 1975;132(2):150-153.
41. Meltzer HY. Evidence-based treatment for reducing suicide risk in schizophrenia. In: Pompili M, Tatarelli R, editors. Evidence-based Practice in Suicidology: A Sourcebook. Göttingen, Germany: Hogrefe; 2010.
42. Pompili M. Exploring the phenomenology of suicide. Suicide Life Threat Behav. 2010;40(3):234-244.
43. Pompili M. From bench to bedside in the prevention of suicide: A never ending back and forth journey. Crisis. 2010;31(2):59-61.